DCGO - DCGO INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that DocGo Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit | Benzinga
SAN DIEGO, Nov. 04, 2023 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of DocGo Inc. (NASDAQ:DCGO) securities between November 8, 2022 and September 17, 2023, both dates inclusive (the "Class Period"), have until December 26, 2023 to seek appointment as lead plaintiff of the DocGo class action lawsuit. Captioned Naclerio v. DocGo Inc., No. 23-cv-09476 (S.D.N.Y.), the DocGo class action lawsuit charges DocGo and certain of its top current and former executive officers with violations of the Securities Exchange Act of 1934.
If you suffered substantial losses and wish to serve as lead plaintiff of the DocGo class action lawsuit, please provide your information here:
https://www.rgrdlaw.com/cases-docgo-inc-class-action-lawsuit-dcgo.html
You can also contact attorney J.C. Sanchez of Robbins Geller by calling 800/449-4900 or via e-mail at jsanchez@rgrdlaw.com.
CASE ALLEGATIONS: DocGo offers mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. According to the complaint, in spring 2023, New York City awarded DocGo a no-bid $432 million contract (the "Relocation Contract") that took effect in early May 2023.
The DocGo class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) DocGo's executive hiring processes were inadequate to fully review and vet the professional and academic backgrounds of job candidates; (ii) this increased the likelihood of disruptive executive turnover; (iii) contrary to DocGo's representations to investors, DocGo had overstated the efficacy of its mobile health and medical transportation services; and (iv) all of the above, once revealed, was likely to ...